Royal Biologics, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$1.6M
Doctors Paid
541
Transactions
2,300
2024 Total
$492,326
Payment Breakdown by Category
Consulting$693,368 (43.6%)
Royalty/License$534,242 (33.6%)
Research$186,782 (11.8%)
Food & Beverage$112,836 (7.1%)
Travel$36,279 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $693,368 | 494 | 43.6% |
| Royalty or License | $534,242 | 136 | 33.6% |
| Unspecified | $186,782 | 42 | 11.8% |
| Food and Beverage | $112,836 | 1,566 | 7.1% |
| Travel and Lodging | $36,279 | 36 | 2.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,800 | 10 | 1.1% |
| Long term medical supply or device loan | $4,624 | 1 | 0.3% |
| Honoraria | $3,500 | 7 | 0.2% |
| Entertainment | $926.09 | 8 | 0.1% |
Payments by Type
General
$1.4M
2,258 transactions
Research
$186,782
32 transactions
Ownership
$0
10 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Platelet Rich Fibrin Matrix in ACDF Surgery: Is it an effective bone grafting option used alone? | $50,929 | 0 | 4 |
| : Single Center Prospective Registry to Evaluate Use and Outcomes of Royal Biologics Products in Spinal Fusion Surgery | $39,000 | 1 | 6 |
| Single Center Prospective Registry to Evaluate Use and Outcomes of Royal Biologics Products in Spinal | $27,750 | 1 | 2 |
| A Randomized Controlled Multicenter Trial, Examining the Effect of Derm-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers | $25,850 | 1 | 9 |
| A PILOT STUDY TO EVALUATE THE EFFICACY OF NON-DIMETHYL SULFOXIDE (NON-DMSO) VIABLE UMBILICAL CORD GRAFT ONDIABETIC FOOT ULCERS | $21,420 | 2 | 2 |
| Single Center Prospective Registry to Evaluate Use and Outcomes of Royal Biologics Products in Spinal Fusion Surgery | $10,250 | 1 | 3 |
| Foot & Ankle Fusion Case Series | $7,250 | 1 | 4 |
| PILOT STUDY TO EVALUATE THE EFFECTS OF PLATELET RICH FIBRIN MATRIX (FIBRINET) ON DIABETIC FOOT ULCERS | $3,085 | 0 | 1 |
| PILOT STUDY TO EVALUATE THE EFFECTS OF PLATELET RICH FIBRIN MATRIX FIBRINET ON DIABETIC FOOT ULCERS | $1,248 | 1 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Grigoriy Arutyunyan, Md, MD | Orthopaedic Surgery | Rochester, MN | $224,458 | $0 |
| Dr. Brad Prybis, Md, MD | Orthopaedic Surgery of the Spine | Roswell, GA | $201,968 | $0 |
| Dr. Robert Wetzel, M.d, M.D | Orthopaedic Surgery | Cleveland, OH | $110,934 | $0 |
| Dr. Ki-Hon Lin, Md, MD | Orthopaedic Surgery of the Spine | Carrollton, GA | $97,895 | $0 |
| Salvatore Zavarella, Do, DO | Neurological Surgery | West Islip, NY | $92,834 | $0 |
| Raz Winiarsky, Md, MD | Orthopaedic Surgery of the Spine | Brooklyn, NY | $68,400 | $0 |
| Dr. Frank Liporace, M.d, M.D | Orthopaedic Trauma | Jersey City, NJ | $55,827 | $0 |
| Dr. Olatunde Osofisan, Dpm, DPM | Sports Medicine | Brooklyn, NY | $53,092 | $0 |
| Mr. Sushil Basra, Md, MD | Orthopaedic Surgery of the Spine | Commack, NY | $26,825 | $0 |
| Ronald Guberman, Dpm, DPM | Foot Surgery | Mamaroneck, NY | $24,333 | $0 |
| Dr. Joseph Larsen, D.p.m, D.P.M | Foot & Ankle Surgery | Garden City Park, NY | $24,306 | $0 |
| Dr. Patrick Doherty, M.d, M.D | Neurological Surgery | New London, CT | $22,890 | $0 |
| Dr. Deena Horn, D.p.m, D.P.M | Foot & Ankle Surgery | New York, NY | $22,549 | $0 |
| Dr. Steven Bernstein, D.p.m, D.P.M | Foot & Ankle Surgery | Fort Lee, NJ | $21,608 | $0 |
| Dr. Robert Fridman, Dpm, DPM | Foot & Ankle Surgery | Bronx, NY | $20,468 | $0 |
| Peter Passias, Md, MD | Orthopaedic Surgery of the Spine | Durham, NC | $19,740 | $0 |
| Angel Macagno, Md, MD | Student in an Organized Health Care Education/Training Program | Westbury, NY | $19,355 | $0 |
| Dr. Charles Gordon, M.d, M.D | Student in an Organized Health Care Education/Training Program | Daphne, AL | $19,148 | $0 |
| Dr. Craig Radnay | Orthopaedic Surgery | Temple Terrace, FL | $18,078 | $0 |
| Dr. John Doolan, Dpm, DPM | Foot & Ankle Surgery | New York, NY | $16,120 | $0 |
| James Yue, Md, MD | Orthopaedic Surgery | Shelton, CT | $15,480 | $0 |
| Faheem Sandhu, M.d, M.D | Neurological Surgery | Clinton, MD | $13,675 | $0 |
| Dr. Joseph Racanelli, Do, DO | Plastic Surgery | Morristown, NJ | $12,750 | $0 |
| Dr. Damon Combs, Dpm, DPM | Foot & Ankle Surgery | Bethel Park, PA | $11,885 | $0 |
| Dr. Jason Snyder, Dpm, DPM | Foot & Ankle Surgery | New York, NY | $10,864 | $0 |
Ad
Top Products
- Fibrinet $332,356
- AmnioMaxx $30,401
Associated Products (8)
Payment Categories
- Food & Beverage $112,836
- Consulting $693,368
- Travel & Lodging $36,279
- Research $186,782
- Royalties $534,242
About Royal Biologics, Inc.
Royal Biologics, Inc. has made $1.6M in payments to 541 healthcare providers, recorded across 2,300 transactions in the CMS Open Payments database. In 2024, the company paid $492,326. The top product by payment volume is Fibrinet ($332,356).
Payments were distributed across 56 medical specialties. The top specialty by payment amount is Orthopaedic Surgery of the Spine ($441,678 to 33 doctors).
Payment categories include: Food & Beverage ($112,836), Consulting ($693,368), Research ($186,782), Travel & Lodging ($36,279), Royalties ($534,242).
Royal Biologics, Inc. is associated with 8 products in the CMS Open Payments database, including Fibrinet, AmnioMaxx, and MaxxCell.